FdaApplication
NDA 217513
Identifiers
- fda_app_no: NDA217513
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2023-03-16 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MEKINIST | TRAMETINIB | 2MG | TABLET;ORAL |
| MEKINIST | TRAMETINIB | 4.7MG | SOLUTION;ORAL |
| MEKINIST | TRAMETINIB DIMETHYL SULFOXIDE | EQ 0.05MG BASE/ML | SOLUTION;ORAL |
3 products